Simponi approved for rheumatoid arthritis

Share this content:
Simponi approved for rheumatoid arthritis
Simponi approved for rheumatoid arthritis
The Food and Drug Administration has approved rheumatoid arthritis drug golimumab. The product is marketed by Pennsylvania-based Centocor Ortho Biotech Inc. and will be sold under the name Simponi. The medication works by blocking tumor necrosis factor, an inflammation often found in rheumatoid arthritis patients.
http://www.centocor.com/centocor/home.html